Abstract
The first quotation describes the situation as the virus lies dormant and asymptomatic and difficult to detect but likely easier to prevent by vaccination, whereas later with the eruption of the characteristic painful rash of herpes zoster (HZ), it becomes easy to diagnose but difficult to treat.
For it happens…in the beginning the malady is easy to cure but difficult to detect but in time, not having been detected or treated, it becomes easy to detect but difficult to cure.
Nicola Machiavelli, The Prince
A kindly understanding doctor who will keep in touch with his patients with intractable postherpetic neuralgia even for a very long time is extremely valuable therapeutically.
Edgar Hope-Simpson [25]
The efficient physician is he who amuses his patients while nature effects a cure.
The philosophical dictionary, Voltaire (1694–1778)
References
Attal N, Cruccu G, Baron R et al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: revision. Eur J Neurol 17:1113–1123
Backonja MD, Wallace MS, Bionski ER et al (2008) NGX-4010, a high concentration capsaicin patch for the treatment of postherpetic neuralgia: a randomized , double-blind study. Lancet Neurol 7(12):1106–1112
Bowsher D (1996) Postherpetic neuralgia and its treatment: a retrospective survey of 191 patients. J Pain Symptom Manage 12:327–331
Brisson M, Pellisier JM, Camden S, Quach C, DeWals S (2008) The potential cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia. Hum Vaccin 4:238–245
Capsaicin patch for postherpetic neuralgia (2011) The Medical Letter 53(Issue 1365):42–43
Chen N, Qifu L, Yang J (2014) Antiviral treatment for preventing postherpetic neuralgia, The Cochrane Collaboration.
Collins SL, Moore RA, McQuay HJ (2000) Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage 20:449–458
Cook RJ, Sackett DL (1995) The number needed to treat: a clinically useful measure of treatment effect. Br Med J ;310:452–454 (review). The Cochrane Collaboration
Coplan PM, Schmader K, Nikas A (2004) Development of a measure of burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials; adaptation of the brief pain inventory. J Pain 5:344–356
Demoragas JM, Kierland RR (1957) The outcome of patients with herpes zoster. Arch Dermatol 75:193–119
Donahue JG, Choo PW, Manson JG et al (1995) The incidence of herpes zoster. Arch Intern Med 155:1605–1609
Drolet M, Brisson M et al (2010) A prospective study of the herpes zoster severity of illness. Clin J Pain 26:656–666
Drolet M, Brisson M, Schmader K et al (2010) Predictors of postherpetic neuralgia among patients with herpes zoster :a prospective study. J Pain 11:1211–1221
Dworkin RH, Corbin AE, Young JP et al (2003) Pregabalin for the treatment of postherpetic neuralgia; a randomized placebo-controlled trial. Neurology 60(8):1274–1283
Dworkin RH, O’Connor AB, Backonja M et al (2007) Pharmacologic management of neuropathic pain:evidence-based recommendations. Pain 132:237–251
Dworkin RH, O’Connor AB, Audette J et al (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85(3 suppl):S3–S14
Dworkin RH, O’Connor AB, Backonja M et al (2007) Pharmacologic management of neuropathic pain:evidence-based recommendations. Pain 132:237–251
Dworkin RH, O’Connor AB, Audette J et al (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85(3 suppl):S3–S14
Finnerup NNB, Sindrup SH, Jensen TS (2010) The evidence for pharmacological treatment of neuropathic pain. Pain 150:573–581
Frieden TR, Houry D (2016) Reducing the risks of relief- the CDC opioid- prescribing guideline. N Engl J Med 374:1501–1504
Gauthier A, Breuer J, Carrington D (2009) Epidemiology and cost of herpes zoster and postherpetic neuralgia in the United Kingdom. Epidemiol Infect 137:38–47
Gilron I, Watson CPN, Cahill CM, Moulin DE (2006) Neuropathic pain: a practical guide for the clinician. CMAJ 175(3):265–275
Head H, Campbell AW (1900) The pathology of herpes zoster and its bearing on sensory localization. Brain 23:353–523
Hope-Simpson RE (1965) The nature of herpes zoster: a long term study and a new hypothesis. Proc R Soc Med 58:9–20
Hope-Simpson RE (2001) Some early investigations into the nature of herpes zoster and postherpetic neuralgia. In: Watson CPN, Gershon AA (eds) Herpes Zoster and postherpetic neuralgia, 2nd revised and enlarged edition. Elsevier, pp 1–12
Insinga DRP, Itzler RF, Pellisier JM et al (2005) The incidence of herpes zoster in a US administrative database. J Intern Med 20(8):748–783
Irving G, Jensen M, Cramer M (2009) Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia. Clin J Pain 25:185–192
Johnson RW, Rice ASC (2014) Postherpetic neuralgia. N Engl J Med 371(16):1526–1532
Kajdasz DK, Iyengar S, Desaiah D et al (2007) Duloxetine for the management of diabetic painful neuropathic pain:evidence-based findings from post-hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel group studies. Clin Ther 29:2536–2546
Kurzke JR (1984) Neuroepidemiology. Ann Neurol 16:265–277
Lal H et al (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372:2087–2096
Lunn MPT, Hughes RAC, Wiffen PJ (2009) Duloxetine for treating painful neuropathy or chronic pain (Review) The Cochrane Collaboration Issue (4):CD007115
Morrison V, Johnson GR, Schmader KE (2015) Long-term persistence of zoster vaccine efficacy. CID 60:900–909
Moulin DE, Clark AJ, Gilron I et al (2007) Pharmacological management of chronic neuropathic pain-Consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12:13–21
Noordenbos W (1959) PAIN: problems pertaining to the transmission of nerve impulses which give rise to pain. Elsevier
Oaklander AL, Romans K, Horasdek S (1998) Unilateral postherpetic neuralgia is associated with bilateral sensory change. Ann Neurol 44:789–795
Oxman MN, Levin MD, Johnson JR (2005) A vaccine to prevent postherpetic neuralgia in older adults. N Engl J Med 352:2271–2284
Ragozzino MW, Melton LJ, Kurland LT (1982) Population-based study of herpes zoster and its sequelae. Medicine 61:310–316
Ragozzino MW, Melton RJ, Kurland LT (1982) Risk of cancer after herpes zoster: a population-based study. N Eng J Med 307:393–397
Rowbotham MC, Davies PS, Verkempinck C et al (1996) Lidocaine patch: a double-blind comtrolled study of a new treatment for postherpetic neuralgia. Pain 65:39
Rowbotham MC, Goli V, Kunz NR et al (2004) Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double blind, placebo-controlled study. Pain 110:697–706
Rowbotham MC, Harden N, Stacey B et al (1998) Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280(21):1837–1842
Saarto T, Wiffen PJ 2010 Antidepressants for neuropathic pain. The Cochrane Collaboration Issue (1):CD005454
Shapiro M, Kvern B, Watson CPN et al (2011) Update on herpes zoster vaccination: A family practioner’s guide. Can Fam Phys 57:1127–1132
Sindrup SH, Jensen TS (1999) Efficacy of pharmacological treatment of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83:389–400
Sindrup SH, Jensen T (2000) Pharmacological treatment of pain in polyneuropathy. Neurology 55:915–920
Sindrup SH, Bach FW, Madsen C et al (2003) Venlafaxine versus imipramine in painful polyneuropathy: a randomized controlled trial. Neurology 60:1284–1289
Van Wijck AJ, Opstelten W, Moore KG et al (2006) The PINE study of epidural steroids and local anesthetics to prevent postherpetic neuralgia: a randomized controlled trial. Lancet 367:219–224
Watson CPN, Morshead C, Van Der Kooy D et al (1988) Postherpetic neuralgia: postmortem analysis of a case. Pain 34:129–138
Watson CPN, Deck JH, Morshead C, Van der Kooy D, Evans RJ (1991) Postherpetic neuralgia: further postmortem studies of cases with and without pain. Pain 44:105–117
Watson CPN, Watt VR, Chipman M, Birkett N, Evans RJ (1991) The prognosis with postherpetic neuralgia. Pain 46:195–199
Watson CPN (2007) External validity of pharmaceutical trials in neuropathic pain. In: Rothwell PM (ed) The Lancet: treating individuals from randomized trials to personalized medicine. Elsevier, pp 121–130
Watson CPN, Gilron I, Sawynok J (2010) A qualitative, systematic review of head-to-head randomized, controlled trials of oral analgesics in neuropathic pain. J Pain Res Manage 15(3):147–157
Watson CPN, Babul N (1998) Oxycodone relieves neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50:1837–1841
Watson CPN, Vernich L, Chipman M, Reed K (1998) Amitriptyline versus nortriptyline in postherpetic neuralgia. Neurology 51:1166–1171
Watson CPN (2011) A death knell for codeine after craniotomy. Can Jnl Neur Sci 38(3):390–391
Watson CPN, Midha R, Devor M, et al (2000) Trigeminal postherpetic neuralgia postmortem: clinically unilateral, pathologically bilateral. In: Devor M, Rowbotham MC, Wiesenfeld–Hallin Z (eds) Proceedings of the 9th world congress on pain
Watson CPN (2001) A tribute to R. Edgar Hope-Simpson, O.B.E., F.R.C.G.P. In: Watson CPN, Gershon A (eds) Herpes zoster and postherpetic neuralgia, Elsevier Science, B.V. Amsterdam, p xxiii
Watson CPN, Gilron I, Sawynok J, Lynch M (2011) Antidepressant analgesics and pain: are serotonin norepinephrine reuptake inhibitors any better? Pain 152:2206–2210
Whitley RJ, Weiss H, Gnann JW et al (1996) Acyclovir with and without prednisone for the treatment of herpes zoster. Ann Intern Med 125:376–383
Wiffen P, Collins S, McQuay H et al (2001) Anticonvulsant drugs for acute and chronic pain. (Cochrane review). The Cochrane library Issue 3 Oxford update software
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Watson, C.P.N. (2017). Postherpetic Neuralgia: Difficult to Treat, Easier to Prevent. In: Watson, C., Gershon, A., Oxman, M. (eds) Herpes Zoster: Postherpetic Neuralgia and Other Complications. Adis, Cham. https://doi.org/10.1007/978-3-319-44348-5_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-44348-5_19
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-44346-1
Online ISBN: 978-3-319-44348-5
eBook Packages: MedicineMedicine (R0)